Signal Pathways Which Promote Invasion and Metastasis: Critical and Distinct Contributions of Extracellular Signal-Regulated Kinase and Ral-Specific Guanine Exchange Factor Pathways

REFERENCES

• Aguirre-Ghiso, J. A., P. Frankel, E. F. Farias, Z. Lu, H. Jiang, A. Olsen, L. A. Feig, E. B. de Kier Joffe, and D. A. Foster. 1999. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene 18:4718–4725.
   PubMedGoogle Scholar
• Anand-Apte, B., B. R. Zetter, A. Viswanathan, R. G. Qiu, J. Chen, R. Ruggieri, and M. Symons. 1997. Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways. J. Biol. Chem. 272:30688–30692.
   PubMed Web of Science ®Google Scholar
• Cantor, S. B., T. Urano, and L. A. Feig. 1995. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol. Cell. Biol. 15:4578–4584.
   PubMed Web of Science ®Google Scholar
• Chambers, A. F., and A. B. Tuck. 1993. Ras-responsive genes and tumor metastasis. Crit. Rev. Oncog. 4:95–114.
   PubMed Web of Science ®Google Scholar
• Chu, Y., P. A. Solski, R. Khosravi-Far, C. J. Der, and K. Kelly. 1996. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271:6497–6501.
   PubMed Web of Science ®Google Scholar
• Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841–852.
   PubMed Web of Science ®Google Scholar
• Cox, A. D., and C. D. Der. 1994. Biological assays for cellular transformation. Methods Enzymol. 238:277–294.
   PubMedGoogle Scholar
• Downward, J.. 1997. Role of phosphoinositide-3-OH kinase in Ras signaling. Adv. Second Messenger Phosphoprot. Res. 31:1–10.
   PubMedGoogle Scholar
• Galang, C. K., C. J. Der, and C. A. Hauser. 1994. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene 9:2913–2921.
   PubMed Web of Science ®Google Scholar
• Gille, H., and J. Downward. 1999. Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem. 274:22033–22040.
   PubMed Web of Science ®Google Scholar
• Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547–5551.
   PubMed Web of Science ®Google Scholar
• Hill, C. S., R. Marais, S. John, J. Wynne, S. Dalton, and R. Treisman. 1993. Functional analysis of a growth factor-responsive transcription factor complex. Cell 73:395–406.
   PubMed Web of Science ®Google Scholar
• Hofer, F., R. Berdeaux, and G. S. Martin. 1998. Ras-independent activation of Ral by a Ca(2+)-dependent pathway. Curr. Biol. 8:839–842.
   PubMedGoogle Scholar
• Huang, W., D. S. Kessler, and R. L. Erikson. 1995. Biochemical and biological analysis of Mek1 phosphorylation site mutants. Mol. Biol. Cell 6:237–245.
   PubMedGoogle Scholar
• Johnson, S. A., N. Mandavia, H. D. Wang, and D. L. Johnson. 2000. Transcriptional regulation of the TATA-binding protein by ras cellular signaling. Mol. Cell. Biol. 20:5000–5009.
   PubMedGoogle Scholar
• Joneson, T., and D. Bar-Sagi. 1997. Ras effectors and their role in mitogenesis and oncogenesis. J. Mol. Med. 75:587–593.
   PubMed Web of Science ®Google Scholar
• Khosravi-Far, R., P. A. Solski, G. J. Clark, M. S. Kinch, and C. J. Der. 1995. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15:6443–6453.
   PubMed Web of Science ®Google Scholar
• Khosravi-Far, R., M. A. White, J. K. Westwick, P. A. Solski, M. Chrzanowska-Wodnicka, L. Van Aelst, M. H. Wigler, and C. J. Der. 1996. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol. 16:3923–3933.
   PubMed Web of Science ®Google Scholar
• Klemke, R. L., S. Cai, A. L. Giannini, P. J. Gallagher, P. de Lanerolle, and D. A. Cheresh. 1997. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137:481–492.
   PubMed Web of Science ®Google Scholar
• Kolch, W., G. Heidecker, P. Lloyd, and U. R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349:426–428.
   PubMed Web of Science ®Google Scholar
• Koop, S., E. E. Schmidt, I. C. MacDonald, V. L. Morris, R. Khokha, M. Grattan, J. Leone, A. F. Chambers, and A. C. Groom. 1996. Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc. Natl. Acad. Sci. USA 93:11080–11084.
   PubMed Web of Science ®Google Scholar
• Leevers, S. J., B. Vanhaesebroeck, and M. D. Waterfield. 1999. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 11:219–225.
   PubMed Web of Science ®Google Scholar
• Luo, J. Q., X. Liu, P. Frankel, T. Rotunda, M. Ramos, J. Flom, H. Jiang, L. A. Feig, A. J. Morris, R. A. Kahn, and D. A. Foster. 1998. Functional association between Arf and RalA in active phospholipase D complex. Proc. Natl. Acad. Sci. USA. 95:3632–3637.
   PubMed Web of Science ®Google Scholar
• Luzzi, K. J., I. C. MacDonald, E. E. Schmidt, N. Kerkvliet, V. L. Morris, A. F. Chambers, and A. C. Groom. 1998. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153:865–873.
   PubMed Web of Science ®Google Scholar
• Marais, R., and C. J. Marshall. 1996. Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv. 27:101–125.
   PubMedGoogle Scholar
• Marshall, C. J.. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185.
   PubMed Web of Science ®Google Scholar
• Miller, M. J., S. Prigent, E. Kupperman, L. Rioux, S. H. Park, J. R. Feramisco, M. A. White, J. L. Rutkowski, and J. L. Meinkoth. 1997. RalGDS functions in Ras- and cAMP-mediated growth stimulation. J. Biol. Chem. 272:5600–5605.
   PubMedGoogle Scholar
• Mulvaney, P. T., M. L. Stracke, S. W. Nam, E. Woodhouse, M. O'Keefe, T. Clair, L. A. Liotta, R. Khaddurah-Daouk, and E. Schiffmann. 1998. Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase. Int. J. Cancer 78:46–52.
   PubMedGoogle Scholar
• Nguyen, D. H., A. D. Catling, D. J. Webb, M. Saukovic, L. A. Walker, A. V. Somlyo, M. J. Weber, and S. L. Gonias. 1999. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. Cell Biol. 146:149–164.
   PubMed Web of Science ®Google Scholar
• Ohta, Y., N. Suzuki, S. Nakamura, J. H. Hartwig, and T. P. Stossel. 1999. The small GTPase RalA targets filamin to induce filopodia. Proc. Natl. Acad. Sci. USA 96:2122–2128.
   PubMed Web of Science ®Google Scholar
• Okazaki, M., S. Kishida, T. Hinoi, T. Hasegawa, M. Tamada, T. Kataoka, and A. Kikuchi. 1997. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator. Oncogene 14:515–521.
   PubMedGoogle Scholar
• Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
   PubMed Web of Science ®Google Scholar
• Ramocki, M. B., M. A. White, S. F. Konieczny, and E. J. Taparowsky. 1998. A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis. J. Biol. Chem. 273:17696–17701.
   PubMedGoogle Scholar
• Rohan, P. J., P. Davis, C. A. Moskaluk, M. Kearns, H. Krutzsch, U. Siebenlist, and K. Kelly. 1993. PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science 259:1763–1766.
   PubMed Web of Science ®Google Scholar
• Schaap, D., J. van der Wal, L. R. Howe, C. J. Marshall, and W. J. van Blitterswijk. 1993. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J. Biol. Chem. 268:20232–20236.
   PubMedGoogle Scholar
• Vanhaesebroeck, B., S. J. Leevers, G. Panayotou, and M. D. Waterfield. 1997. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22:267–272.
   PubMed Web of Science ®Google Scholar
• Verheijen, M. H., R. M. Wolthuis, L. H. Defize, J. den Hertog, and J. L. Bos. 1999. Interdependent action of RalGEF and Erk in Ras-induced primitive endoderm differentiation of F9 embryonal carcinoma cells. Oncogene 18:4435–4439.
   PubMedGoogle Scholar
• Wasylyk, C., B. Wasylyk, G. Heidecker, M. Huleihel, and U. R. Rapp. 1989. Expression of raf oncogenes activates the PEA1 transcription factor motif. Mol. Cell. Biol. 9:2247–2250.
   PubMedGoogle Scholar
• Webb, C. P., L. Van Aelst, M. H. Wigler, and G. F. Woude. 1998. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc. Natl. Acad. Sci. USA 95:8773–8778.
   PubMedGoogle Scholar
• White, M. A., C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M. H. Wigler. 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80:533–541.
   PubMed Web of Science ®Google Scholar
• White, M. A., T. Vale, J. H. Camonis, E. Schaefer, and M. H. Wigler. 1996. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J. Biol. Chem. 271:16439–16442.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R. M., and J. L. Bos. 1999. Ras caught in another affair: the exchange factors for Ral. Curr. Opin. Genet. Dev. 9:112–117.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R. M., N. D. de Ruiter, R. H. Cool, and J. L. Bos. 1997. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 16:6748–6761.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R. M., B. Franke, M. van Triest, B. Bauer, R. H. Cool, J. H. Camonis, J. W. Akkerman, and J. L. Bos. 1998. Activation of the small GTPase Ral in platelets. Mol. Cell. Biol. 18:2486–2491.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R. M., F. Zwartkruis, T. C. Moen, and J. L. Bos. 1998. Ras-dependent activation of the small GTPase Ral. Curr. Biol. 8:471–474.
   PubMed Web of Science ®Google Scholar
• Xie, H., T. Turner, M. H. Wang, R. K. Singh, G. P. Siegal, and A. Wells. 1995. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin. Exp. Metastasis 13:407–419.
   PubMed Web of Science ®Google Scholar